Asclera is a highly effective and safe sclerosing agent that is administered through a specialized injection process. The mechanism of action for Asclera involves the deliberate injury of the endothelium, which is the cellular lining inside blood vessels. This induces the adhesion of blood platelets and cellular debris, which in turn leads to the formation of a blood clot that ultimately replaces the clotted vein with new tissue. Asclera has been demonstrated to produce significant improvements in treating vascular conditions, providing patients with the effective and reliable treatment they require to overcome their medical concerns. Through its unique mechanism of action, Asclera is able to yield superior results, thereby benefiting medical professionals and patients alike.